...
首页> 外文期刊>Infection and immunity >Branched-Chain Amino Acids Are Required for the Survival and Virulence of Actinobacillus pleuropneumoniae in Swine
【24h】

Branched-Chain Amino Acids Are Required for the Survival and Virulence of Actinobacillus pleuropneumoniae in Swine

机译:猪胸膜肺炎放线杆菌的生存和毒力需要支链氨基酸。

获取原文
           

摘要

In Actinobacillus pleuropneumoniae, which causes porcine pleuropneumonia, ilvI was identified as an in vivo-induced (ivi) gene and encodes the enzyme acetohydroxyacid synthase (AHAS) required for branched-chain amino acid (BCAA) biosynthesis. ilvI and 7 of 32 additional ivi promoters were upregulated in vitro when grown in chemically defined medium (CDM) lacking BCAA. Based on these observations, we hypothesized that BCAA would be found at limiting concentrations in pulmonary secretions and that A. pleuropneumoniae mutants unable to synthesize BCAA would be attenuated in a porcine infection model. Quantitation of free amino acids in porcine pulmonary epithelial lining fluid showed concentrations of BCAA ranging from 8 to 30 μmol/liter, which is 10 to 17% of the concentration in plasma. The expression of both ilvI and lrp, a global regulator that is required for ilvI expression, was strongly upregulated in CDM containing concentrations of BCAA similar to those found in pulmonary secretions. Deletion-disruption mutants of ilvI and lrp were both auxotrophic for BCAA in CDM and attenuated compared to wild-type A. pleuropneumoniae in competitive index experiments in a pig infection model. Wild-type A. pleuropneumoniae grew in CDM+BCAA but not in CDM?BCAA in the presence of sulfonylurea AHAS inhibitors. These results clearly demonstrate that BCAA availability is limited in the lungs and support the hypothesis that A. pleuropneumoniae, and potentially other pulmonary pathogens, uses limitation of BCAA as a cue to regulate the expression of genes required for survival and virulence. These results further suggest a potential role for AHAS inhibitors as antimicrobial agents against pulmonary pathogens.
机译:在导致猪胸膜肺炎的胸膜肺炎放线杆菌中, ilvI 被鉴定为体内诱导的( ivi )基因,并编码乙酰羟酸合酶( AHAS)是支链氨基酸(BCAA)生物合成所必需的。当在缺乏BCAA的化学定义培养基(CDM)中生长时, ilvI 和32个其他 ivi 启动子中的7个在体外被上调。基于这些观察,我们假设在肺分泌物中的极限浓度和 A中会发现BCAA。在猪感染模型中,不能合成BCAA的胸膜肺炎突变体将被减弱。猪肺上皮内衬液中游离氨基酸的定量显示,BCAA的浓度为8至30μmol/ L,为血浆中浓度的10至17%。 ilvI lrp ilvI 表达所需的全局调节子)的表达在含有BCAA浓度的CDM中强烈上调,类似于在肺部分泌物中发现的那些。与野生型 A相比, ilvI lrp 的缺失-破坏突变体对BCAA都是营养缺陷的,并且相对于野生型 A而言是减毒的。猪感染模型中竞争性肺炎支原体肺炎。野生型 A。在磺酰脲类AHAS抑制剂的存在下,胸膜肺炎在CDM + BCAA中生长,而在CDM?BCAA中不生长。这些结果清楚地表明,肺中BCAA的可用性有限,并支持 A的假设。胸膜肺炎以及其他潜在的肺部病原体,利用BCAA的限制来调节存活和致病性所需基因的表达。这些结果进一步表明AHAS抑制剂作为抗肺病原体的抗菌剂的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号